Nuclear Medicine Imaging in Pediatric Neurology

Overview

Journal Mol Imaging Radionucl Ther

Date 2016 Jun 15

PMID 27299282

Citations 1

Authors

Umit Ozgur Akdemir

Lutfiye Ozlem Atay Kapucu

Affiliations

Soon will be listed here.

Abstract

Nuclear medicine imaging can provide important complementary information in the management of pediatric patients with neurological diseases. Pre-surgical localization of the epileptogenic focus in medically refractory epilepsy patients is the most common indication for nuclear medicine imaging in pediatric neurology. In patients with temporal lobe epilepsy, nuclear medicine imaging is particularly useful when magnetic resonance imaging findings are normal or its findings are discordant with electroencephalogram findings. In pediatric patients with brain tumors, nuclear medicine imaging can be clinically helpful in the diagnosis, directing biopsy, planning therapy, differentiating tumor recurrence from post-treatment sequelae, and assessment of response to therapy. Among other neurological diseases in which nuclear medicine has proved to be useful are patients with head trauma, inflammatory-infectious diseases and hypoxic-ischemic encephalopathy.

Citing Articles

Methods for Monitoring Risk of Hypoxic Damage in Fetal and Neonatal Brains: A Review.

Uzianbaeva L, Yan Y, Joshi T, Yin N, Hsu C, Hernandez-Andrade E Fetal Diagn Ther. 2021; 49(1-2):1-24.

PMID: 34872080 PMC: 8983560. DOI: 10.1159/000520987.

References

Saha G, MACINTYRE W, Go R . Radiopharmaceuticals for brain imaging. Semin Nucl Med. 1994; 24(4):324-49. DOI: 10.1016/s0001-2998(05)80022-4. View

Pirotte B, Goldman S, Massager N, David P, Wikler D, Lipszyc M . Combined use of 18F-fluorodeoxyglucose and 11C-methionine in 45 positron emission tomography-guided stereotactic brain biopsies. J Neurosurg. 2004; 101(3):476-83. DOI: 10.3171/jns.2004.101.3.0476. View

Tripathi M, Sharma R, Dsouza M, Jaimini A, Panwar P, Varshney R . Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas. Clin Nucl Med. 2010; 34(12):878-83. DOI: 10.1097/RLU.0b013e3181becfe0. View

Galldiks N, Kracht L, Berthold F, Miletic H, Klein J, Herholz K . [11C]-L-methionine positron emission tomography in the management of children and young adults with brain tumors. J Neurooncol. 2009; 96(2):231-9. PMC: 2808525. DOI: 10.1007/s11060-009-9953-x. View

Goffin K, Dedeurwaerdere S, Van Laere K, Van Paesschen W . Neuronuclear assessment of patients with epilepsy. Semin Nucl Med. 2008; 38(4):227-39. DOI: 10.1053/j.semnuclmed.2008.02.004. View

Kazemi N, Worrell G, Stead S, Brinkmann B, Mullan B, OBrien T . Ictal SPECT statistical parametric mapping in temporal lobe epilepsy surgery. Neurology. 2009; 74(1):70-6. PMC: 3462472. DOI: 10.1212/WNL.0b013e3181c7da20. View

Holzer T, Herholz K, Jeske J, Heiss W . FDG-PET as a prognostic indicator in radiochemotherapy of glioblastoma. J Comput Assist Tomogr. 1993; 17(5):681-7. DOI: 10.1097/00004728-199309000-00002. View

OBrien T, Miles K, Ware R, Cook M, Binns D, Hicks R . The cost-effective use of 18F-FDG PET in the presurgical evaluation of medically refractory focal epilepsy. J Nucl Med. 2008; 49(6):931-7. DOI: 10.2967/jnumed.107.048207. View

Kapucu L, Gucuyener K, Vural G, Kose G, Tokcaer A, Turgut B . Brain SPECT evaluation of patients with pure photosensitive epilepsy. J Nucl Med. 1996; 37(11):1755-9. View

10.

Tan K, Britton J, Buchhalter J, Worrell G, Lagerlund T, Shin C . Influence of subtraction ictal SPECT on surgical management in focal epilepsy of indeterminate localization: a prospective study. Epilepsy Res. 2008; 82(2-3):190-3. DOI: 10.1016/j.eplepsyres.2008.08.007. View

11.

Sood S, Chugani H . Functional neuroimaging in the preoperative evaluation of children with drug-resistant epilepsy. Childs Nerv Syst. 2006; 22(8):810-20. DOI: 10.1007/s00381-006-0137-0. View

12.

Worley G, Hoffman J, Paine S, Kalman S, Claerhout S, Boyko O . 18-Fluorodeoxyglucose positron emission tomography in children and adolescents with traumatic brain injury. Dev Med Child Neurol. 1995; 37(3):213-20. DOI: 10.1111/j.1469-8749.1995.tb11994.x. View

13.

Utriainen M, Metsahonkala L, Salmi T, Utriainen T, Kalimo H, Pihko H . Metabolic characterization of childhood brain tumors: comparison of 18F-fluorodeoxyglucose and 11C-methionine positron emission tomography. Cancer. 2002; 95(6):1376-86. DOI: 10.1002/cncr.10798. View

14.

Blum D, Ehsan T, Dungan D, Karis J, Fisher R . Bilateral temporal hypometabolism in epilepsy. Epilepsia. 1998; 39(6):651-9. DOI: 10.1111/j.1528-1157.1998.tb01434.x. View

15.

Patil S, Biassoni L, Borgwardt L . Nuclear medicine in pediatric neurology and neurosurgery: epilepsy and brain tumors. Semin Nucl Med. 2007; 37(5):357-81. DOI: 10.1053/j.semnuclmed.2007.04.002. View

16.

Shi Y, Zhao J, Liu L, Hu Z, Tang S, Chen L . Changes of positron emission tomography in newborn infants at different gestational ages, and neonatal hypoxic-ischemic encephalopathy. Pediatr Neurol. 2012; 46(2):116-23. DOI: 10.1016/j.pediatrneurol.2011.11.005. View

17.

Chugani H . A critical period of brain development: studies of cerebral glucose utilization with PET. Prev Med. 1998; 27(2):184-8. DOI: 10.1006/pmed.1998.0274. View

18.

Hwang S, Kim J, Park S, Han M, Yu I, Lee S . Comparative analysis of MR imaging, positron emission tomography, and ictal single-photon emission CT in patients with neocortical epilepsy. AJNR Am J Neuroradiol. 2001; 22(5):937-46. PMC: 8174931. View

19.

Van Laere K, Varrone A, Booij J, Vander Borght T, Nobili F, Kapucu O . EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2. Eur J Nucl Med Mol Imaging. 2009; 37(2):434-42. DOI: 10.1007/s00259-009-1265-z. View

20.

Lorberboym M, Lampl Y, Gerzon I, Sadeh M . Brain SPECT evaluation of amnestic ED patients after mild head trauma. Am J Emerg Med. 2002; 20(4):310-3. DOI: 10.1053/ajem.2002.34201. View